Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	n.A.	n.A.	11.01
Graham Fair Price	n.A.	n.A.	34.33
PEG	284.14	-0.30	0.08
Price/Book	inf	0.00	0.89
Price/Cash Flow	inf	0.00	66.25
Prices/Earnings	114.02	13.84	6.46
Price/Sales	269.46	13.27	3.59
Price/FCF	inf	0.00	66.25
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	-5.74	0.63	0.67
Operating Margin	5.17	0.27	0.26
ROA	inf	0.00	0.02
ROE	0.03	0.00	inf
ROIC	0.04	0.00	inf
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.97	-0.67	-66.03
EPS QOQ	0.82	-0.46	-44.29
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	2.11	-0.69	-67.57
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-230.69	n.A.	n.A.
Days Sales Outstanding (DSO)	14.68	n.A.	n.A.
Inventory Turnover	-0.39	0.00	inf
Debt/Capitalization	0.02	0.00	inf
Quick Ratio	0.68	0.00	inf
Naive Interpretation	member

04 - Leverage & Liquidity · Not Interpreted

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	38.96	n.A.	n.A.
Cash	7.48	n.A.	n.A.
Capex	-0.26	n.A.	n.A.
Free Cash Flow	0.53	n.A.	n.A.
Revenue	9.69	3.05	-68.56
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	0.70	0.00	inf
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.42	n.A.	n.A.
Naive Interpretation	Member

06 - Financial Health · Not Interpreted

Rating